- Home
- GELS vs PRPH Comparison
GELS vs PRPH Comparison
Compare GELS & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GELS
- PRPH
- Stock Information
- Founded
- GELS 2018
- PRPH 1989
- Country
- GELS Australia
- PRPH United States
- Employees
- GELS N/A
- PRPH N/A
- Industry
- GELS
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- GELS
- PRPH Health Care
- Exchange
- GELS NYSE
- PRPH Nasdaq
- Market Cap
- GELS 15.9M
- PRPH 15.2M
- IPO Year
- GELS 2024
- PRPH 1997
- Fundamental
- Price
- GELS $1.73
- PRPH $0.40
- Analyst Decision
- GELS
- PRPH
- Analyst Count
- GELS 0
- PRPH 0
- Target Price
- GELS N/A
- PRPH N/A
- AVG Volume (30 Days)
- GELS 4.0M
- PRPH 4.1M
- Earning Date
- GELS 02-15-2025
- PRPH 08-13-2025
- Dividend Yield
- GELS N/A
- PRPH N/A
- EPS Growth
- GELS N/A
- PRPH N/A
- EPS
- GELS N/A
- PRPH N/A
- Revenue
- GELS $233,830.00
- PRPH $5,845,000.00
- Revenue This Year
- GELS N/A
- PRPH $221.82
- Revenue Next Year
- GELS N/A
- PRPH N/A
- P/E Ratio
- GELS N/A
- PRPH N/A
- Revenue Growth
- GELS 10.19
- PRPH N/A
- 52 Week Low
- GELS $0.77
- PRPH $0.22
- 52 Week High
- GELS $5.50
- PRPH $3.74
- Technical
- Relative Strength Index (RSI)
- GELS N/A
- PRPH 64.99
- Support Level
- GELS N/A
- PRPH $0.32
- Resistance Level
- GELS N/A
- PRPH $0.37
- Average True Range (ATR)
- GELS 0.00
- PRPH 0.03
- MACD
- GELS 0.00
- PRPH 0.01
- Stochastic Oscillator
- GELS 0.00
- PRPH 90.91
About GELS GELTEQ LIMITED
Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.